For the studies reported here, we used BRAF mutant A375 and Colo829 melanoma cell clones (A375/R and Colo829/R respectively) that were over 100‐fold less sensitive to the BRAF inhibitor PLX4720 than their respective parental cells (Supplemental Figure 1A). Here, BRAF is linked to melanoma.